| Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study KW Garey, M Rege, MP Pai, DE Mingo, KJ Suda, RS Turpin, DT Bearden Clinical infectious diseases 43 (1), 25-31, 2006 | 1436 | 2006 |
| Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the … MJ Rybak, J Le, TP Lodise, DP Levine, JS Bradley, C Liu, BA Mueller, ... American Journal of Health-System Pharmacy 77 (11), 835-864, 2020 | 1151 | 2020 |
| The origin of the “ideal” body weight equations MP Pai, FP Paloucek Annals of Pharmacotherapy 34 (9), 1066-1069, 2000 | 462 | 2000 |
| Antimicrobial dosing considerations in obese adult patients: insights from the Society of Infectious Diseases Pharmacists MP Pai, DT Bearden Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (8 …, 2007 | 327 | 2007 |
| Innovative approaches to optimizing the delivery of vancomycin in individual patients MP Pai, M Neely, KA Rodvold, TP Lodise Advanced drug delivery reviews 77, 50-57, 2014 | 301 | 2014 |
| Vancomycin: we can't get there from here N Patel, MP Pai, KA Rodvold, B Lomaestro, GL Drusano, TP Lodise Clinical infectious diseases 52 (8), 969-974, 2011 | 296 | 2011 |
| Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults MP Pai Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (9 …, 2012 | 239 | 2012 |
| Estimation of creatinine clearance in morbidly obese patients JA Demirovic, AB Pai, MP Pai American Journal of Health-System Pharmacy 66 (7), 642-648, 2009 | 207 | 2009 |
| Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia MP Pai, RS Turpin, KW Garey Antimicrobial agents and chemotherapy 51 (1), 35-39, 2007 | 185 | 2007 |
| Estimating the glomerular filtration rate in obese adult patients for drug dosing MP Pai Advances in chronic kidney disease 17 (5), e53-e62, 2010 | 168 | 2010 |
| Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia M Falcone, A Russo, M Venditti, A Novelli, MP Pai Clinical infectious diseases 57 (11), 1568-1576, 2013 | 148 | 2013 |
| The effects of obesity on drug pharmacokinetics in humans GA Morrish, MP Pai, B Green Expert opinion on drug metabolism & toxicology 7 (6), 697-706, 2011 | 126 | 2011 |
| Risk Factors Associated with the Development of Infection with Linezolid- and Vancomycin-Resistant Enterococcus faecium MP Pai, KA Rodvold, PC Schreckenberger, RD Gonzales, JM Petrolatti, ... Clinical infectious diseases 35 (10), 1269-1272, 2002 | 122 | 2002 |
| Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin MP Pai, JP Norenberg, T Anderson, DW Goade, KA Rodvold, RA Telepak, ... Antimicrobial agents and chemotherapy 51 (8), 2741-2747, 2007 | 115 | 2007 |
| Macrolide drug interactions: an update MP Pai, DM Graci, GW Amsden Annals of Pharmacotherapy 34 (4), 495-513, 2000 | 108 | 2000 |
| Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline … MJ Rybak, J Le, T Lodise, D Levine, J Bradley, C Liu, B Mueller, M Pai, ... Journal of the Pediatric Infectious Diseases Society 9 (3), 281-284, 2020 | 106 | 2020 |
| Renal dosing of antibiotics: are we jumping the gun? RL Crass, KA Rodvold, BA Mueller, MP Pai Clinical Infectious Diseases 68 (9), 1596-1602, 2019 | 104 | 2019 |
| Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients MP Pai, AN Nafziger, JS Bertino Jr Antimicrobial agents and chemotherapy 55 (9), 4006-4011, 2011 | 98 | 2011 |
| Antibiotic drug interactions MP Pai, KM Momary, KA Rodvold Medical Clinics 90 (6), 1223-1255, 2006 | 95 | 2006 |
| Reappraisal of linezolid dosing in renal impairment to improve safety RL Crass, PG Cojutti, MP Pai, F Pea Antimicrobial agents and chemotherapy 63 (8), 10.1128/aac. 00605-19, 2019 | 90 | 2019 |
